Device firms are going to plan accordingly and try to control their costs ahead of a planned 2013 device tax, says Morningstar analyst Julie Stralow .
Get our sector-by-sector take on the bond market, plus our five best bond ideas.
Morningstar OptionInvestor editor Erik Kobayashi-Solomon and senior health-care analyst Julie Stralow discuss Intuitive Surgical's appeal and outlook.
Morningstar's Julie Stralow sees opportunities in both the debt and equity of medical device firms Stryker and Zimmer.
Even if a potential Sanofi/Genzyme deal foretells a wave of consolidation, investors shouldn't worry about big pharma credit quality, says Morningstar's Julie Stralow .
Get our sector-by-sector take on the bond markets, plus our five best bond ideas.
Medical-device expansion in the BRIC countries will accelerate as price points are lowered and more doctors learn how to use orthopedics, says Smith & Nephew's Phil Cowdy.
If long-term investors can see beyond reform uncertainty, they could make a great return on Stryker shares.
Morningstar's Brian Nelson reviews the performance of our corporate credit ratings on their one-year anniversary of their launch, plus two health-care bond picks.
Morningstar's credit research team makes the case for health care, retail, and racetrack credits.